Central Automotive Products (8117) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
26 May, 2026Executive summary
Revenue for the nine months ended December 2024 rose 2.9% year-over-year to ¥30,362 million, with operating profit up 6.1% to ¥8,181 million and net profit attributable to shareholders up 8.3% to ¥6,456 million.
The company acquired K.M. Enterprise in December 2024, expanding its overseas auto parts business.
Domestic new car sales declined 3.2% year-over-year, but the company focused on high-value products and new customer acquisition.
Financial highlights
Operating profit margin improved, with operating profit at ¥8,181 million (up 6.1% year-over-year).
Net profit per share increased to ¥350.83 from ¥324.07 year-over-year.
Comprehensive income for the period was ¥6,314 million, down 6.8% year-over-year.
Total assets increased to ¥61,329 million, and equity ratio rose to 87.4%.
Outlook and guidance
Full-year revenue forecast is ¥41,000 million (up 4.2% year-over-year), with operating profit projected at ¥10,800 million (up 6.2%) and net profit at ¥8,100 million (up 2.2%).
No changes to previously announced earnings guidance as performance is tracking to plan.
Latest events from Central Automotive Products
- Q1 FY2025 delivered stable profits and improved equity despite weak new car sales.8117
Q1 202526 May 2026 - Modest profit growth and higher dividends, with improved equity ratio and stable outlook.8117
Q2 202526 May 2026 - Sales and profits rose, with robust cash flow and a positive outlook for FY2026.8117
Q4 202526 May 2026 - Strong quarterly growth in sales and profits, with positive full-year guidance and stock split.8117
Q1 202626 May 2026 - Net sales and profits grew year-over-year, with strong guidance and a recent stock split.8117
Q2 202626 May 2026 - Net sales rose 12.8% and profit attributable to owners of parent increased 11.7% year-over-year.8117
Q3 202626 May 2026 - Sales and profits rose, cash flow strengthened, and FY2027 guidance remains positive.8117
Q4 202626 May 2026